Perspective | Published:

The Pediatric Cancer Genome Project

Nature Genetics volume 44, pages 619622 (2012) | Download Citation

  • An Erratum to this article was published on 29 August 2012

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 09 July 2012

    In the version of this article initially published, there were errors in the labeling of Figure 1b. Specifically, hyperdiploidy was mislabeled twice as hypodiploidy, and hypodiploidy was defined incorrectly as >44 instead of <44 chromosomes. These errors have been corrected in the HTML and PDF versions of the article.

References

  1. 1.

    Anonymous. News briefing. Childhood cancers. Nature 463, 407 (2010).

  2. 2.

    et al. Challenging issues in pediatric oncology. Nat. Rev. Clin. Oncol. 8, 540–549 (2011).

  3. 3.

    et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr. Blood Cancer 58, 334–343 (2012).

  4. 4.

    , & Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012).

  5. 5.

    et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012).

  6. 6.

    , & Computational methods for discovering structural variation with next-generation sequencing. Nat. Methods 6, S13–S20 (2009).

  7. 7.

    et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat. Methods 8, 652–654 (2011).

  8. 8.

    et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251–253 (2012).

  9. 9.

    et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235–239 (2011).

  10. 10.

    et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181–185 (2010).

  11. 11.

    et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521–523 (2009).

  12. 12.

    et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 482, 226–231 (2012).

  13. 13.

    The Cancer Genome Atlas Research Network. An integrated genomic analysis of human glioblastoma multiforme. Nature 455, 1061–1068 (2008).

  14. 14.

    et al. Driver mutations in histone 3.3 and chromatin remodelling genes in paediatric glioblastoma. Science 321, 1807–1812 (2008).

  15. 15.

    et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. J. Am. Med. Assoc. 307, 1062–1071 (2012).

  16. 16.

    et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 157–163 (2012).

  17. 17.

    The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).

  18. 18.

    et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010).

  19. 19.

    et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).

  20. 20.

    et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia–initiating cells. Nature 469, 362–367 (2011).

  21. 21.

    et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322, 1377–1380 (2008).

  22. 22.

    et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816 (2007).

Download references

Acknowledgements

We thank H. Inaba, C. Mullighan, K. Roberts, S. Ramondi, S.-C. Chen, D. Pei and J. Groff for their extensive contributions to and diligence in preparing Figure 1, and we thank X. Chen for contributions to Figure 2. We would also like to thank M. Rusch and P. Nagahawatte for their contributions to data submission to EBI and dbGaP. This work was funded by The St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, an NCI Cancer Center support grant (P30 CA021765), the US National Institutes of Health (NIH; U01 GM 92666 and R37 CA36401 to St. Jude Children's Research Hospital), grants to R.K.W. from Washington University in St. Louis and a grant from the NHGRI (U54 HG003079 to Washington University in St. Louis).

Author information

Affiliations

  1. St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, Memphis, Tennessee, USA.

    • James R Downing
    • , Jinghui Zhang
    • , Ching-Hon Pui
    •  & William E Evans
  2. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

    • James R Downing
    •  & Ching-Hon Pui
  3. St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, St. Louis, Missouri, USA.

    • Richard K Wilson
    • , Elaine R Mardis
    • , Li Ding
    •  & Timothy J Ley
  4. The Genome Institute at Washington University, St. Louis, Missouri, USA.

    • Richard K Wilson
    • , Elaine R Mardis
    • , Li Ding
    •  & Timothy J Ley
  5. Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

    • Jinghui Zhang
  6. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

    • Ching-Hon Pui
  7. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

    • William E Evans

Authors

  1. Search for James R Downing in:

  2. Search for Richard K Wilson in:

  3. Search for Jinghui Zhang in:

  4. Search for Elaine R Mardis in:

  5. Search for Ching-Hon Pui in:

  6. Search for Li Ding in:

  7. Search for Timothy J Ley in:

  8. Search for William E Evans in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to James R Downing or William E Evans.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng.2287

Further reading